Placebo + Sevelamer carbonate
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hyperphosphatemia
Conditions
Hyperphosphatemia, Chronic Kidney Disease
Trial Timeline
May 1, 2012 → Jun 1, 2015
NCT ID
NCT01574326About Placebo + Sevelamer carbonate
Placebo + Sevelamer carbonate is a phase 2 stage product being developed by Sanofi for Hyperphosphatemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01574326. Target conditions include Hyperphosphatemia, Chronic Kidney Disease.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01574326 | Phase 2 | Completed |
| NCT01220843 | Phase 3 | Completed |
| NCT01736150 | Phase 3 | Completed |
Competing Products
20 competing products in Hyperphosphatemia